Beauty Health (NASDAQ:SKIN – Get Rating) will be announcing its earnings results after the market closes on Tuesday, May 10th. Beauty Health has set its FY 2022 guidance at EPS.Investors interested in registering for the company’s conference call can do so using this link.
Beauty Health (NASDAQ:SKIN – Get Rating) last announced its earnings results on Tuesday, February 22nd. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.04. The company had revenue of $77.90 million during the quarter, compared to analysts’ expectations of $70.90 million. The company’s revenue was up 106.1% compared to the same quarter last year. On average, analysts expect Beauty Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Shares of NASDAQ:SKIN opened at $13.76 on Tuesday. Beauty Health has a 52-week low of $11.12 and a 52-week high of $30.17. The firm has a fifty day moving average of $16.55 and a 200 day moving average of $19.81. The company has a current ratio of 13.09, a quick ratio of 12.63 and a debt-to-equity ratio of 2.41.
Several analysts have issued reports on the stock. DA Davidson upped their price target on shares of Beauty Health from $32.00 to $35.00 and gave the company a “buy” rating in a research report on Wednesday, February 23rd. William Blair assumed coverage on shares of Beauty Health in a research report on Friday, January 7th. They set an “outperform” rating for the company. Piper Sandler cut their price target on shares of Beauty Health from $31.00 to $26.00 in a research report on Thursday, April 28th. JPMorgan Chase & Co. assumed coverage on shares of Beauty Health in a research report on Friday, March 11th. They set an “overweight” rating and a $24.00 price target for the company. Finally, Benchmark upped their price target on shares of Beauty Health from $18.00 to $23.00 and gave the company a “buy” rating in a research report on Monday, March 14th. One equities research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Buy” and an average price target of $27.20.
Beauty Health Company Profile (Get Rating)
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
- Get a free copy of the StockNews.com research report on Beauty Health (SKIN)
- Tractor Supply Stock Should Plow Ahead
- MarketBeat Podcast: Investing In Innovation, Robotics, AI and Healthcare
- It’s Time to Book an Appointment for Teladoc Stock
- GitLab Stock is Trying to Put in a Bottom Here
- Saia Growth Accelerates But It May Not Matter
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.